HomeREGULATORY
REGULATORY

Health Minister Pitches Revision to Corporate Eligibility Criteria for Price Maintenance Premium: CEFP
(May.24.2017)

Health Minister Yasuhisa Shiozaki set out a plan on May 23 to modify not only the scope of products eligible for the so-called price maintenance premium for on-patent drugs but also its eligibility criteria for drug makers - a move apparently aimed at soothing criticism that the premium is benefiting foreign companies, rather than Japanese players ...
(LOG IN FOR FULL STORY)

News Calendar